SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 23.09 |
Enterprise Value ($M) | 19.02 |
Book Value ($M) | 3.82 |
Book Value / Share | 0.44 |
Price / Book | 6.04 |
NCAV ($M) | 3.82 |
NCAV / Share | 0.44 |
Price / NCAV | 6.05 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.65 |
Return on Assets (ROA) | -2.37 |
Return on Equity (ROE) | -2.54 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.90 |
Current Ratio | 5.90 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 4.60 |
Assets | 4.60 |
Liabilities | 0.78 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Empery Asset Management, LP |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
177,350 | 743,778 | 23.84 | |
254,953 | 919,588 | 27.72 | |
27,740 | 160,084 | 17.33 | |
118,756 | 388,016 | 30.61 | |
(click for more detail) |
Similar Companies | |
---|---|
BCDA – BioCardia, Inc. | BCLI – Brainstorm Cell Therapeutics Inc. |
BCTX – BriaCell Therapeutics Corp. | BFRI – Biofrontera Inc. |
BGM – BGM Group Ltd. |
Financial data and stock pages provided by
Fintel.io